Literature DB >> 19070384

Progression of diabetic nephropathy in type 1 diabetic patients.

Behzad Najafian1, Michael Mauer.   

Abstract

Understanding pathogenetic mechanisms of diabetic nephropathy progression risk factors is important. Structural-functional relationship studies have increased our understanding of the glomerular, vascular and tubulointerstitial lesions evolution at various stages of diabetic nephropathy. Classical and more recently described lesions of diabetic nephropathy are discussed. Structural changes associated with progression toward proteinuria and GFR loss are summarized. The relationships of renal structure and function in diabetic nephropathy are best described by non-linear models which mimic the natural history of the disease, i.e., renal pathology develops in clinical silence but, once established, leads to proteinuria and GFR decline.

Entities:  

Mesh:

Year:  2008        PMID: 19070384     DOI: 10.1016/j.diabres.2008.08.024

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  14 in total

1.  Reversibility of structural and functional damage in a model of advanced diabetic nephropathy.

Authors:  Warangkana Pichaiwong; Kelly L Hudkins; Tomasz Wietecha; Tri Q Nguyen; Chiraporn Tachaudomdach; Wei Li; Bardia Askari; Takahisa Kobayashi; Kevin D O'Brien; Jeffrey W Pippin; Stuart J Shankland; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

Review 2.  The goal of blood pressure control for prevention of early diabetic microvascular complications.

Authors:  Mark E Williams
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

3.  Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria.

Authors:  Shin-ichi Araki; Masakazu Haneda; Daisuke Koya; Keiji Isshiki; Shinji Kume; Toshiro Sugimoto; Hiromichi Kawai; Yoshihiko Nishio; Atsunori Kashiwagi; Takashi Uzu; Hiroshi Maegawa
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 19.112

4.  Transcriptomic analysis in diabetic nephropathy of streptozotocin-induced diabetic rats.

Authors:  Consuelo Lomas-Soria; Minerva Ramos-Gómez; Lorenzo Guevara-Olvera; Ramón Guevara-González; Irineo Torres-Pacheco; Marco A Gallegos-Corona; Rosalía Reynoso-Camacho
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

5.  Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.

Authors:  Makoto Sawaguchi; Shin-Ichi Araki; Hiroyuki Kobori; Maki Urushihara; Masakazu Haneda; Daisuke Koya; Atsunori Kashiwagi; Takashi Uzu; Hiroshi Maegawa
Journal:  J Diabetes Investig       Date:  2011-11-08       Impact factor: 4.232

6.  Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes.

Authors:  Hiroshi Okada; Takafumi Senmaru; Michiaki Fukui; Yoshitaka Kondo; Akihito Ishigami; Naoki Maruyama; Hiroshi Obayashi; Masahiro Yamazaki; Naoto Nakamura; Goji Hasegawa
Journal:  J Diabetes Investig       Date:  2014-07-07       Impact factor: 4.232

7.  Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.

Authors:  Sara Stridh; Fredrik Palm; Tomoko Takahashi; Mayumi Ikegami-Kawai; Peter Hansell
Journal:  Ups J Med Sci       Date:  2015-07-14       Impact factor: 2.384

8.  Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus?

Authors:  Ülkü Gül Şiraz; Murat Doğan; Nihal Hatipoğlu; Sabahattin Muhtaroğlu; Selim Kurtoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-05-22

9.  Vegfa protects the glomerular microvasculature in diabetes.

Authors:  Gavasker A Sivaskandarajah; Marie Jeansson; Yoshiro Maezawa; Vera Eremina; Hans J Baelde; Susan E Quaggin
Journal:  Diabetes       Date:  2012-11       Impact factor: 9.461

10.  A hyaluronan synthesis inhibitor delays the progression of diabetic kidney disease in a mouse experimental model.

Authors:  Guillermo Selman; Laisel Martinez; Andrea Lightle; Alejandra Aguilar; Daniel Woltmann; Yuxuan Xiao; Roberto I Vazquez-Padron; Loay H Salman
Journal:  Kidney360       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.